Green Elephant Biotech has introduced Archimedes One, the first system in a new category called the Dynamic Adherent Bioreactor. The company is introducing the platform to the market ahead of its planned commercial launch later this year. Archimedes One was developed to address a central challenge in cell therapy manufacturing: how to scale adherent cell processes without compromising biology or introducing unnecessary complexity. Instead of forcing adherent cells into suspension or comple...